HOXB2 and breast carcinoma: To assess the functional role of HOXB2 in breast cancer progression, HOXB2 was knocked down in T47D ER+ breast cancer cell lines using siRNAs (Fig. 2a, b), followed by trans-well invasion and migration assays.